Nitrophenols
Sigma Aldrich 3,5-Dinitrosalicylic acid
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
Sigma Aldrich methyldodecylbenzyl trimethyl ammonium chloride
MilliporeSigma Sigma Organics products encompass a wide range of quality reagents, solvents, catalysts, and building blocks for organic synthesis. From benchtop discovery to process development and scale-up, Sigma Organics solutions are built to meet the needs of synthetic chemists.
TARGETMOL CHEMICALS INC STO-609 10MG
Also available in 1 mL, 1 mg, 5 mg, 25 mg, 50 mg, 100 mg, 500 mg and bulk. Please contact Fisher for quotes. STO-609 is a specific and cell-permeable inhibitor of the Ca2+/calmodulin-dependent protein kinase kinase (CaM-KK) for recombinant CaM-KKalpha/KKbeta (Ki 80/15 ng/mL). Purity 98.95%
Selleck Chemical LLC FHD-609-E1859-25MG
FHD-609 acts as a selective inhibitor and degrader of BRD9 protein (bromodomain-containing protein 9) FHD-609 targets ncBAF and can be used in research of various cancers involving mutations in a BAF complex subunit
Selleck Chemical LLC FHD-609-E1859-1G
FHD-609 acts as a selective inhibitor and degrader of BRD9 protein (bromodomain-containing protein 9) FHD-609 targets ncBAF and can be used in research of various cancers involving mutations in a BAF complex subunit
Chem-Impex International, Inc. 3,5-Dinitrosalicylic acid | 609-99-4 | MFCD00007104 | 100G
3,5-Dinitrosalicylic acid, 609-99-4, MFCD00007104, 100G
Medchemexpress LLC Fhd-609 | 2676211-64-4 | 99.2% | 829.00 | C47H56N8O6 | 10 MG
FHD-609 is a selective heterobifunctional degrader (PROTAC) of bromodomain-containing protein 9 (BRD9). It induces targeted proteasomal degradation via CRBN recruitment and is used in research to study BRD9 biology, ncBAF complex function, and oncology-related applications. The compound is supplied as a high-purity material for laboratory use and formulation work.
- Selective BRD9 degrader and inhibitor.
- High purity (>99%) suitable for research use.
- Applicable to in vitro and preclinical studies.
- Facilitates study of ncBAF complex and BRD9-related cancers.
- Molecular weight 829.00 and formula C47H56N8O6.
![Medchemexpress LLC 7-oxo-7H-benzimidazo[2,1-a]benzo[de]isoquinoline-3-carboxylic acid | 52029-86-4 | MFCD30685721 | 98.2% | 314.29 | C19H10N2O3 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000297549.png-250.jpg)
Medchemexpress LLC 7-oxo-7H-benzimidazo[2,1-a]benzo[de]isoquinoline-3-carboxylic acid | 52029-86-4 | MFCD30685721 | 98.2% | 314.29 | C19H10N2O3 | 10 MG
STO-609 is a selective, cell-permeable inhibitor of calmodulin-dependent protein kinase kinase (CaMKK) used as a research tool to probe CaMKK/CaMK and AMPK signaling pathways in biochemical and cell-based studies. The compound is supplied as a solid research reagent with documented purity, solubility, and storage recommendations for laboratory use.
- Selective inhibitor of CaMKK with activity against CaMKKα and CaMKKβ.
- Cell-permeable small molecule suitable for cellular assays.
- Useful probe for AMPK and autophagy pathway studies.
- Purity 98.2% by HPLC.
- Molecular weight 314.29; formula C19H10N2O3; CAS 52029-86-4.
- Available in small research sizes, including 10 mg.
- Solubility varies by vehicle; soluble in DMSO and PEG-containing formulations.
- Store sealed at 4°C; in solvent, store at -80°C for long-term stability.
Apexbio Technology LLC STO-609 acetate 1173022-21-3 5mg
STO-609 acetate (CAS 1173022-21-3) is a selective inhibitor of Ca2 /calmodulin-dependent protein kinase kinase (CaM-KK) demonstrating Ki values of 80 ng/ml for CaM-KK and 15 ng/ml for CaM-KK This compound exhibits marked specificity for CaM-KK isoforms with minimal activity against downstream CaM kinases such as CaM-KI and CaM-KIV and an IC50 of approximately 10 g/ml for CaM-KII In cell-based studies STO-609 suppresses Ca2 -induced activation of CaM-KIV and reduces endogenous CaM-KK activity In vivo STO-609 administration enhances osteoblast formation and inhibits osteoclast differentiation in mouse models highlighting its utility in studies of calcium signaling and bone metabolism